$CTSH

Cognizant Stock Falls 3.8%—Is CTSH Cheap at 10 Times Earnings?

Cognizant (CTSH) shares fell 3.8% to $59.92, trading at 10.4x its 2026 EPS forecast. Q2 revenue rose 4.5% to $5.48B, with adjusted EPS up 4.6% to $1.37. Bookings declined 6% YoY, raising concerns. Management revised revenue growth guidance to 4.0%-5.5% and raised EPS guidance to $5.70-$5.82. Investors weigh AI's impact on growth and margins.

Original reporting
Published Sep 9, 2026, 2:42 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 10:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cognizant Stock Falls 3.8%—Is CTSH Cheap at 10 Times Earnings? — source image
Decision brief

The 30-second read

$CTSHNeutralMed
01

Why it matters

The new EPS guidance and mixed bookings data create a nuanced outlook, influencing both valuation and sector sentiment.

02

Market read

Earnings and guidance release is material for traders; the stock's price move and valuation debate make it a notable market mover.

03

What to watch

Cognizant's $1.6B buyback and $2.3B remaining authorization provide significant shareholder return capacity.

Relevance 8/10Novelty 8/10Timing: post‑close Tuesday

Background

Cognizant is a leading U.S. IT‑services provider navigating AI transformation.

Company-level read

Ticker impact

$CTSHNeutralMedium confidence
Context

Cognizant disclosed Q2 results and raised FY2026 adjusted EPS guidance to $5.70‑$5.82, prompting a 3.8% price drop.

Expected impact

Potential modest upside if earnings beat expectations; downside risk if bookings remain weak.

Evidence & confidence

Guidance is new and material, but the mixed signal of higher EPS versus soft bookings creates uncertainty.

Market effects

IT services sector may face valuation pressure as AI automation concerns rise.

U.S. tech stocks could see modest pullback amid earnings‑driven risk aversion.

Limited; primarily affects U.S. listed IT‑services firms.

Counterpoint

The dividend yield and strong cash returns could support the stock despite AI‑related margin risks.

Key entities

  • Cognizant Technology Solutions Corp.

    U.S. listed IT‑services firm (ticker CTSH).

Related articles

$CTSHMedAI 8/10

US halts Cognizant's green-card filings amid Trump's visa fraud crackdown

The US has suspended Cognizant's permanent labor certification filings amid a visa fraud probe. The move is part of a broader crackdown by the Trump administration. Cognizant, a major H-1B sponsor, faces scrutiny over alleged fraud in its visa programs. The suspension bars new PERM applications until the investigation concludes. According to US Citizenship and Immigration Services, Cognizant had 3,510 H-1B visa approvals as of June 30, down from 9,413 in 2020.

$CTSHHighAI 8/10

US Suspends Cognizant’s PERM Filings, Who's Next?

The US Department of Labor suspended Cognizant's PERM filings, citing potential fraud in H-1B and PERM programs. The investigation involves the White House Fraud Task Force. Cognizant's new filings are blocked, but existing approvals and H-1B visas remain unaffected. This action may increase scrutiny on other IT firms like TCS, Infosys, and Wipro.

$CTSHMedAI 8/10

Cognizant's AI Gamble: What Nearshore Must Learn

Cognizant reported Q2 2026 revenue growth of 4.5%, down from Q2 2025, but beat peers and met guidance. Bookings fell 6% YoY. The company raised full-year EPS guidance to $5.70-$5.82, and its stock surged 41.81% in a month. Cognizant cited AI-led demand and partnerships with Google Cloud and Anthropic.

$CTSHMed

Anthropic Is Only Part of the Story. Cognizant Has a Much Bigger AI Plan.

Cognizant (CTSH) trades at a discount versus its historical valuation, with forward GAAP P/E of 8.31x and P/S of 0.97x. In Q2, it reported EPS $1.37 vs $1.38 expected, 4.5% revenue growth, and $459M free cash flow. Management guided Q3 growth 3.8%-5.3% YoY and FY EPS to $5.76 midpoint. Guggenheim cut its price target to $65 but kept a Buy; analysts’ mean target is $60.12.